首页> 外文OA文献 >Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

【2h】

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

机译：脂质体Irinotecan Plus Fluyouracil / Leucovorin用于转移性胰腺腺癌的临床结果，以前用常规的含氨基甘丹化疗治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kyunghye Bang; Jaekyung Cheon; Jae Ho Jeong; Hyeon-Su Im; Kyu-pyo Kim; Baek-Yeol Ryoo; Changhoon Yoo;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group [J] . Changhoon Yoo, Hyeon-Su Im, Kyu-pyo Kim, Therapeutic advances in medical oncology. . 2019,第12期

机译：脂质体IRINOTECAN PLUS氟尿嘧啶/ Leucovorin在转移性胰腺癌患者中的实际疗效和安全性：韩国癌症研究组的研究
2. 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma. [J] . Assaf E, Verlinde Carvalho M, Delbaldo C, Oncology: International Journal of Cancer Research and Treatment . 2011,第5a6期

机译：5-氟尿嘧啶/亚叶酸钙联合伊立替康和奥沙利铂（FOLFIRINOX）作为转移性胰腺癌患者的二线化疗。
3. IMPUTING MISSING VALUES TO ESTIMATE HEALTH-RELATED QUALITY OF LIFE (HR-QOL) IN METASTATIC PANCREATIC CANCER (MPC) TREATED WITH 5-FLUOROURACIL AND LEUCOVORIN, WITH AND WITHOUT LIPOSOMAL IRINOTECAN (NAL-IRI) [J] . Amzal B., Senecal M., de Jong F. A., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：抵消缺失的值以估计用5-氟尿嘧啶和白杨蛋白处理的转移性胰腺癌（MPC）中的健康相关的寿命质量（HR-QOL），有和没有脂质体IRINOTECAN（NAL-IRI）
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Clinical and Economic Outcomes for Gastric Cancer Patients Treated with Gastrectomy at Centres with and without Cancer Surgery Designation in Ontario [D] . Jeong, Yunni . 2019

机译：安大略省患有癌症手术指定胃癌治疗胃癌患者的胃癌患者的临床和经济结果
6. Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy [O] . Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, 2021

机译：脂质体Irinotecan Plus Fluyouracil / Leucovorin用于转移性胰腺腺癌的临床结果以前用常规的含氨基甘丹化疗治疗
7. A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer [O] . Z. Wainberg, P. Boland, C. Lieu, 2019

机译：脂质体Irinotecan（NAL-IRI）加上5-氟尿嘧啶/白杨（5-FU / LV）和oxaliplatin（牛）的脂质体IRINOTECAN（NAL-IRI）和Oxaliplatin（牛）的阶段1/2，开放标签，剂量 - 扩展性研究

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅